Here you will find all the research and views on GLAND PHARMA that we post on Equitymaster. Use the tools to customize the results to suit your preference!
Here's an analysis of the annual report of GLAND PHARMA for 2023-24. It includes a full income statement, balance sheet and cash flow analysis of GLAND PHARMA. Also includes updates on the valuation of GLAND PHARMA.
Check out GLAND PHARMA fact sheet and GLAND PHARMA financial results online at Equitymaster.
Check out latest GLAND PHARMA Quarterly Results online at Equitymaster.
GLANCE FINAN: Get the latest GLANCE FINAN Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com.
GLAND PHARMA: Get the latest GLAND PHARMA Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com.
Here are five stocks that are ready to profit from the fed rate cut.
The recent drug shortage in US is accelerating exports and sales of these pharma companies.
Shares of Gland Pharma have spiked around 30% in 2 days after declaring Q1 results. What next?
China plus one, government's PLI scheme, and growing consumption are driving the growth of these five pharma companies.
Back-to-back weak quarterly results and supply chain disruptions sent Gland Pharma shares down over 50% in 2022. The downtrend has continued in 2023.
The Hyderabad-based pharma company is facing serious supply constraints.
These power companies are rapidly expanding their capabilities to capture the growing demand for renewable energy. Find out who has a better chance.
The new vaccine business is expected to accelerate the company's long-term strategy of entering into the biosimilar space.